Dexamethasone intravitreal implant as an adjuvant treatment for pediatric patients with Coats' disease / Implante intravítreo de dexametasona como tratamento adjuvante em pacientes pediátricos com doença de Coats
Dorado, Ana Maria; De-Pablo-Cabrera, Almudena; Muñoz-Gallego, Alicia; Moreno-García, Luis; Barceló-Mendiguchía, Ana.
Arq. bras. oftalmol
; 86(4): 380-383, July-Sep. 2023. tab, graf
Artículo
en Inglés
|
LILACS-Express
| ID: biblio-1447369
ABSTRACT We report two cases of stage 3A unilateral Coats' disease in pediatric patients. In both cases, disease control was achieved using a dexamethasone intravitreal implant in addition to other treatments. The treatment improved visual acuity in one patient and prevented the worsening of the decline in visual acuity in the other patient during follow-up periods of 7 and 3 years, respectively. One of the patients presented an increase in intraocular pressure, which was controlled with topical antiglaucoma medication, but developed a cataract that required surgery. In conclusion, dexamethasone intravitreal implant may be a useful adjuvant treatment to consider in some pediatric cases with Coats' disease.
Biblioteca responsable:
BR1.1
Texto completo
Documentos relacionados